Literature DB >> 21239745

Cartilage destruction is partly induced by the internal proteolytic enzymes and apoptotic phenomenon of chondrocytes in relapsing polychondritis.

Naohisa Ouchi1, Miwa Uzuki, Akihisa Kamataki, Yasuhiro Miura, Takashi Sawai.   

Abstract

OBJECTIVE: We analyzed 9 cases by immunohistochemical studies in order to elucidate the mechanisms of cartilage destruction in relapsing polychondritis (RP), which often involves the external auricle and respiratory tract through immunological disorder.
METHODS: Cartilage tissues were obtained during surgical operations. Cell species in the granulation tissues, especially near the cartilage, were identified by cell-surface markers [CD3, CD4, CD8, CD20, CD45 (LCA), and CD68]. The proteolytic enzymes expressed in the cells in the perichondral granulation and in chondrocytes themselves were analyzed by immunohistochemical studies using anti-matrix metalloproteinase (MMP) -1, -3, -8, -9, and -13, and cathepsin D, K, L, and elastase antibodies. Apoptosis and nitric oxide (NO), an apoptosis-related factor, were also examined using ApopTag and antinitrotyrosine antibody, respectively.
RESULTS: Among cell species that infiltrated in perichondral granulation, LCA, CD68 (monocytes/macrophages), and CD4 cells were dominant in number; MMP-8, MMP-9, and elastase were expressed only in the perichondral granulation; whereas MMP-3 and cathepsin K and L were detected in both chondrocytes and granulations. Out of 9 cases examined, 6 revealed apoptotic cells in excess of 50% of chondrocytes. There was a strong correlation between the number of apoptotic cells and the number of MMP-3-positive (r = 0.83) and cathepsin K-positive cells (r = 0.92). Abundant NO-expressing cells were observed in the chondrocytes in degenerated cartilage, similar to apoptosis.
CONCLUSION: Cartilage destruction in polychondritis is induced not only by perichondral inflammation, but also by intrinsic factors expressed in chondrocytes themselves, including certain kinds of proteolytic enzymes and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239745     DOI: 10.3899/jrheum.101044

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 2.  Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Authors:  Ghassan Elourimi; Michael Soussan; Ursula Warzocha; Hélène Bugaud; Robin Dhôte; Sébastien Abad
Journal:  Rheumatol Int       Date:  2017-09-30       Impact factor: 2.631

3.  Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.

Authors:  Maisa O Al-Sebaei; Dana M Daukss; Anna C Belkina; Sanjeev Kakar; Nathan A Wigner; Daniel Cusher; Dana Graves; Thomas Einhorn; Elise Morgan; Louis C Gerstenfeld
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

4.  A nationwide study of the epidemiology of relapsing polychondritis.

Authors:  Anna Horváth; Nóra Páll; Katalin Molnár; Tamás Kováts; György Surján; Tamás Vicsek; Péter Pollner
Journal:  Clin Epidemiol       Date:  2016-06-23       Impact factor: 4.790

5.  Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis.

Authors:  Saskia R Veldkamp; Marc H A Jansen; Joost F Swart; Caroline A Lindemans
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 6.  Refractory relapsing polychondritis: challenges and solutions.

Authors:  Fernando Kemta Lekpa; Xavier Chevalier
Journal:  Open Access Rheumatol       Date:  2018-01-09

Review 7.  Relapsing Polychondritis: An Updated Review.

Authors:  Francesco Borgia; Roberta Giuffrida; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-08-02

8.  Case report of mixed-type autoimmune hemolytic anemia in a patient with relapsing polychondritis.

Authors:  Qianyun Xu; Hui Luo; Xiaoxia Zuo; Sijia Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

9.  Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre.

Authors:  Shirish Dubey; Colin Gelder; Grace Pink; Asad Ali; Christopher Taylor; Joanna Shakespeare; Susan Townsend; Patrick Murphy; Nicholas Hart; David D'Cruz
Journal:  ERJ Open Res       Date:  2021-02-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.